Equities
Health CareHealth Care Equipment & Services
  • Price (GBX)222.60
  • Today's Change-0.40 / -0.18%
  • Shares traded2.56m
  • 1 Year change+9.22%
  • Beta0.7019
Data delayed at least 20 minutes, as of May 12 2021 16:35 BST.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Key statistics

On Wednesday, ConvaTec Group PLC (CTEC:LSE) closed at 222.60, -4.99% below its 52-week high of 234.30, set on May 07, 2021.
52-week range
Today
173.20Oct 09 2020234.30May 07 2021
Markit short selling activity
Low
Med
High
Open223.00
High224.50
Low221.20
Bid195.00
Offer253.00
Previous close223.00
Average volume4.92m
Shares outstanding2.00bn
Free float1.60bn
P/E (TTM)56.15
Market cap4.46bn GBP
EPS (TTM)0.0397
GBP
Annual div (ADY)4.15
GBX
Annual div yield (ADY)1.86%
Div ex-dateApr 01 2021
Div pay-dateMay 13 2021
Data delayed at least 20 minutes, as of May 12 2021 16:35 BST.
More ▼

Investors Chronicle View

The last IC recommendation on ConvaTec Group PLC shares was Sell at 202.00 on 06 Aug 2020Read the full article

Board of Directors

1/10

Dr John McAdam, Chairman

2/10

Karim Bitar, Chief Executive Officer

3/10

Frank Schulkes, Chief Financial Officer

4/10

Margaret Ewing, Senior Independent Non-Executive Director

5/10

Rick Anderson, Independent Non-Executive Director

6/10

Dr Regina Benjamin, Independent Non-Executive Director

7/10

Sten Scheibye, Non-Executive Director

8/10

Professor Constantin-C. Coussios, Independent Non-Executive Director

9/10

Brian May, Independent Non-Executive Director

10/10

Heather Mason, Independent Non-Executive Director

Contact

ConvaTec Group Plc: 3 Forbury Place 23 Forbury Road Reading RG1 3JH
T: + 44 (0) 118 952 8100 W: www.convatecgroup.com

Investor Relations:
T: +44 (0)118 952 8123
E: investorrelations@convatec.com

Financial Public Relations:
Buchanan
Charles Ryland T:+44 (0)207 466 5000 E: convatec@buchanan.uk.com

2020 Full Year Results

Refinitiv, an LSEG business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.